NEXOBRID
- Product NDC
- 69866-2002
- 11-digit product format
- 698662002
- Labeler code
- 69866
- Product ID
- 69866-2002_ff0f85be-f19b-4307-90df-b06be0ac71a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ANACAULASE-BCDB
- Dosage form
- KIT
- Route
- TOPICAL
- Labeler
- Vericel Corporation
- Application
- BLA761192
- Marketing category
- BLA
- Marketing start
- 2022-12-29
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NEXOBRID
- Listing expiration
- 2026-12-31
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Rxcui | 2626751, 2626754, 2626757, 2626758 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69866-2000-1 | NEXOBRID | 2 g in 1 VIAL, GLASS | POWDER | 2 g | 158 mg in 1g | 10 |
| 69866-2002-3 | NEXOBRID | 1 in 1 CARTON | KIT | 1 | | 10 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69866-2002 | NEXOBRID (ANACAULASE-BCDB) KIT [VERICEL CORPORATION] | 9 | Current NDC, 2 package rows | 20250212_1a2f23ad-78ef-43fa-9864-6bd77aac9e57.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 2626751 | anacaulase-bcdb 8.8 % Topical Gel, 22 GM | PSN | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626757 | anacaulase-bcdb 8.8 % Topical Gel, 55 GM | PSN | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626754 | NexoBrid 8.8 % Topical Gel, 22 GM | PSN | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626758 | NexoBrid 8.8 % Topical Gel, 55 GM | PSN | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626754 | 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid] | SBD | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626758 | 55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid] | SBD | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626751 | 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel | SCD | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626757 | 55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel | SCD | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626754 | 22000 MG Nexobrid 0.088 MG/MG Topical Gel | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626758 | 55000 MG Nexobrid 0.088 MG/MG Topical Gel | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626751 | anacaulase-bcdb 8.8 % Topical Gel, 22 GM | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626757 | anacaulase-bcdb 8.8 % Topical Gel, 55 GM | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626754 | Nexobrid 8.8 % Topical Gel, 22 GM | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
| 2626758 | Nexobrid 8.8 % Topical Gel, 55 GM | SY | 1a2f23ad-78ef-43fa-9864-6bd77aac9e57 | 10 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69866-2000-1 | 69866200001 | 2 g in 1 VIAL, GLASS | 2 g | | | | Historical |
| 69866-2002-3 | 69866200203 | 1 KIT in 1 CARTON (69866-2002-3) * 20 g in 1 JAR (69866-2001-2) * 2 g in 1 VIAL, GLASS (69866-2000-1) | 1 kit | 2022-12-29 | No | No | Current |